Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab.
Kirk
A D
AD
Hale
D A
DA
Swanson
S J
SJ
Mannon
R B
RB
D000328:Adult; D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000009:adverse effects*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D008212:Lymphocyte Depletion / Q000379:methods; D013967:Thyroiditis, Autoimmune / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000074323:Alemtuzumab